Background Image
Menu

Latest News

Cytox MedNous coverage: Genetic risk assessment in Alzheimer's disease

25 February 2020

Cytox MedNous coverage: Genetic risk assessment in Alzheimer's disease

Dr Alex Gibson, Business Development Officer at Cytox discusses in MedNous how to predict a person’s genetic risk of developing Alzheimer's using Polygenic Risk Scores. First application is identifying patients most suitable to enter clinical trials, based on risk of significant cognitive decline.

Cytox GeneticRiskADAlexGibson Feb 2020